Historical salary details - Mr. Daniel K. Spiegelman, Independent Director, Maze Therapeutics Inc.
Mr. Daniel K. Spiegelman is the Independent Director of Maze Therapeutics Inc.. They also hold 2 other positions in Kyverna Therapeutics Inc. and Myriad Genetics, Inc..
Mr. Daniel K. Spiegelman
Independent Director
$ 189.4 K
Gross Remuneration
-
Current Company
Maze Therapeutics Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Maze Therapeutics Inc. | Independent Director | 118.1 K | - |
| 2024 | Kyverna Therapeutics Inc. | Independent Director | 71.3 K | -70.9 % |
| 2024 | Myriad Genetics, Inc. | Independent Director | - | - |
| 2023 | Myriad Genetics, Inc. | Independent Director | 433.5 K | - |
| 2023 | Kyverna Therapeutics Inc. | Independent Director | 245.1 K | - |
| 2023 | Spruce Biosciences Inc | Independent Director | 106.9 K | 26.2 % |
| 2023 | Opthea Limited - ADR | Independent Director | - | - |
| 2022 | Opthea Limited - ADR | Independent Director | 771.2 K | -50.3 % |
| 2022 | Spruce Biosciences Inc | Independent Director | 84.7 K | - |
| 2022 | Myriad Genetics, Inc. | Independent Director | - | - |
| 2021 | Opthea Limited - ADR | Independent Director | 1.6 M | - |
| 2021 | Myriad Genetics, Inc. | Independent Director | 451.5 K | 46.0 % |
| 2021 | Spruce Biosciences Inc | Independent Director | - | - |
| 2020 | Myriad Genetics, Inc. | Independent Director | 359.6 K | - |
| 2020 | Myriad Genetics, Inc. | - | 309.2 K | - |
| 2020 | Spruce Biosciences Inc | Independent Director | 234.4 K | - |
| 2019 | Spruce Biosciences Inc | Independent Director | - | - |
| 2012 | Omeros Corporation | - | 55.2 K | -7.7 % |
| 2012 | Cyclacel Pharmaceuticals Inc | - | 23.8 K | -74.5 % |
| 2012 | Cyclacel Pharmaceuticals Inc | Independent Director | - | - |
| 2012 | Omeros Corporation | Independent Director | - | - |
| 2011 | Cyclacel Pharmaceuticals Inc | Independent Director | 93.5 K | -11.5 % |
| 2011 | Omeros Corporation | Independent Director | 59.8 K | 36.8 % |
| 2010 | Cyclacel Pharmaceuticals Inc | Independent Director | 105.7 K | 119.7 % |
| 2010 | Omeros Corporation | Independent Director | 43.8 K | -60.1 % |
| 2009 | Omeros Corporation | Director | 109.7 K | - |
| 2009 | Cyclacel Pharmaceuticals Inc | Director | 48.1 K | -42.9 % |
| 2008 | Cyclacel Pharmaceuticals Inc | Director | 84.2 K | -55.4 % |
| 2007 | Cyclacel Pharmaceuticals Inc | Director | 188.7 K | 50.9 % |
| 2006 | Cyclacel Pharmaceuticals Inc | Director | 125.0 K | - |
| 2005 | Cyclacel Pharmaceuticals Inc | Director | - | - |